The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Assessing Toxicity of Fine and Nanoparticles: Comparing In Vitro Measurements to In Vivo Pulmonary Toxicity Profiles
Abstract
Previous studies have reported little correlation between the relative toxicity of particle types when comparing lung toxicity rankings following in vivo instillation versus in vitro cell culture exposures. This study was designed to assess the capacity of in vitro screening studies to predict in vivo pulmonary toxicity of several fine or nanoscale particle types in rats. In the in vivo component of the study, rats were exposed by intratracheal instillation to 1 or 5 mg/kg of the following particle types: (1) carbonyl iron (CI), (2) crystalline silica (CS) (Min-U-Sil 5, alpha-quartz), (3) precipitated amorphous silica (AS), (4) nano-sized zinc oxide (NZO), or (5) fine-sized zinc oxide (FZO). Depending on particle type and solution state, these particles range in size from 90 to 500 nm in size. Following exposures, the lungs of exposed rats were lavaged and inflammation (neutrophil recruitment) and cytotoxicity end points (bronchoalveolar lavage [BAL] fluid lactate dehydrogenase [LDH] values) were measured at 24 h, 1 week, 1 and 3 months postexposure. For the in vitro component of the study, three different culture conditions were utilized. Cultures of (1) rat L2 lung epithelial cells, (2) primary alveolar macrophages (AMs) (collected via BAL from unexposed rats), as well as (3) AM-L2 lung epithelial cell cocultures were incubated with the particle types listed above, and the culture fluids were evaluated for cytotoxicity end points (LDH, 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan [MTT]) as well as inflammatory cytokines (macrophage inflammatory 2 protein [MIP-2], tumor necrosis factor alpha [TNF-alpha], and interleukin-6 [IL-6]) at one (i.e., cytokines) or several (cytotoxicity) time periods. Results of in vivo pulmonary toxicity studies demonstrated that instilled CI particles produced little toxicity. CS particles produced sustained inflammation and cytotoxicity. AS particles produced reversible and transient inflammatory responses. NZO or FZO particles produced potent but reversible inflammation which was resolved by 1 month postinstillation exposure. Results of in vitro pulmonary cytotoxicity studies demonstrated a variety of responses to the different particle types, primarily at high doses. With respect to the LDH results, L2 cells were the most sensitive and exposures to nano- or fine-sized ZnO for 4 or 24 h were more cytotoxic than exposures to CS or AS particles. Macrophages essentially were resistant and epithelial macrophage cocultures generally reflected the epithelial results at 4 and 24 h incubation, but not at 48 h incubation. MTT results were also interesting but, except for nano- and fine-sized ZnO, did not correlate well with LDH results. Results of in vitro pulmonary inflammation studies demonstrated that L2 cells did not produce MIP-2 cytokines, but CS- or AS-exposed AMs and, to a lesser degree, cocultures secreted these chemotactic factors into the culture media. Measurements of TNF-alpha in the culture media by particle-exposed cells demonstrated little activity. In addition, IL-6 secretion was measured in CS, AS, and nano-sized ZnO-exposed cocultures. When considering the range of toxicity end points to five different particle types, the comparisons of in vivo and in vitro measurements demonstrated little correlation, particularly when considering many of the variables assessed in this study-such as cell types to be utilized, culture conditions and time course of exposure, as well as measured end points. It seems clear that in vitro cellular systems will need to be further developed, standardized, and validated (relative to in vivo effects) in order to provide useful screening data on the relative toxicity of inhaled particle types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Adsorption of Gases in Multimolecular Layers
Brunauer, S., Emmett, P. H., & Teller, E. (1938) · Journal of the American Chemical Society · doi:10.1021/ja01269a023 · Cited by 28,156
Dynamic Light Scattering: Applications of Photon Correlation Spectroscopy
(1985) · Springer eBooks · doi:10.1007/978-1-4613-2389-1 · Cited by 4,856
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.1 · Cited by 2,069
Safe handling of nanotechnology
Maynard, A. D., Aitken, R. J., Butz, T., Colvin, V., Donaldson, K., Oberdörster, G., Philbert, M. A., Ryan, J., Seaton, A., Stone, V., et al. (2006) · Nature · doi:10.1038/444267a · Cited by 1,496
Self-citationBiological and clinical aspects of interleukin 6
Hirano, T., Akira, S., Taga, T., & Kishimoto, T. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90173-7 · Cited by 1,066
Macromolecular Crystallography Part A
(1997) · Methods in Enzymology · doi:10.1016/s0076-6879(00)x0162-0 · Cited by 784
Pesce, A. J., & Kaplan, L. A. (1987) · Mosby eBooks · Cited by 452
Identification and characterization of macrophage inflammatory protein 2.
Wolpe, S. D., Sherry, B., Juers, D., Davatelis, G., Yurt, R. W., & Cerami, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.612 · Cited by 425
Widmer, U., Manogue, K. R., Cerami, A., & Sherry, B. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.4996 · Cited by 251
Cited by
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Sharifi, S., Behzadi, S., Laurent, S., Laird Forrest, M., Stroeve, P., & Mahmoudi, M. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15188f · Cited by 1,460
Rasmussen, J. W., Martinez, E., Louka, P., & Wingett, D. G. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.502560 · Cited by 1,330
NanoGenotoxicology: The DNA damaging potential of engineered nanomaterials
Singh, N., Manshian, B., Jenkins, G. J. S., Griffiths, S. M., Williams, P. M., Maffeis, T. G. G., Wright, C. J., & Doak, S. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.009 · Cited by 1,184
Magnetic nanoparticles for theragnostics
Shubayev, V. I., Pisanic, T. R., & Jin, S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.007 · Cited by 1,028
Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology
Oberdörster, G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02187.x · Cited by 943
The nanosilica hazard: another variable entity
Napierska, D., Thomassen, L. C., Lison, D., Martens, J. A., & Hoet, P. H. (2010) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-7-39 · Cited by 806
Nanodiamond Particles: Properties and Perspectives for Bioapplications
Schrand, A. M., Hens, S. A. C., & Shenderova, O. A. (2009) · Critical Reviews in Solid State and Materials Sciences · doi:10.1080/10408430902831987 · Cited by 802
Fadeel, B., & Garcia-Bennett, A. E. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.008 · Cited by 783
Metal‐based nanoparticles and their toxicity assessment
Schrand, A. M., Rahman, M. F., Hussain, S. M., Schlager, J. J., Smith, D. A., & Syed, A. F. (2010) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.103 · Cited by 753
Nanotoxicity: the growing need for in vivo study
Fischer, H. C., & Chan, W. C. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.11.008 · Cited by 717
Potential toxicity of polystyrene microplastic particles
Hwang, J., Choi, D., Han, S., Jung, S. Y., Choi, J., & Hong, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-64464-9 · Cited by 699
Toxicity of Nanoparticles and an Overview of Current Experimental Models.
Bahadar, H., Maqbool, F., Niaz, K., & Abdollahi, M. R. (2016) · PubMed · doi:10.7508/ibj.2016.01.001 · Cited by 643
Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles
Song, W., Zhang, J., Guo, J., Zhang, J., Ding, F., Li, L., & Sun, Z. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.10.003 · Cited by 636
Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles
Magdolenova, Z., Collins, A., Kumar, A., Dhawan, A., Stone, V., & Dusinska, M. (2014) · Nanotoxicology · doi:10.3109/17435390.2013.773464 · Cited by 616
Superparamagnetic Iron Oxide Nanoparticles—Current and Prospective Medical Applications
Dulińska-Litewka, J., Łazarczyk, A., Hałubiec, P., Szafrański, O., Karnas, K., & Karewicz, A. (2019) · Materials · doi:10.3390/ma12040617 · Cited by 580
In vitro assessments of nanomaterial toxicity
Jones, C. F., & Grainger, D. W. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.005 · Cited by 554
Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro
Park, E.-J., & Park, K. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2008.10.012 · Cited by 524
WARHEIT, D., HOKE, R., FINLAY, C., DONNER, E., REED, K., & SAYES, C. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.04.008 · Cited by 507
Self-citationA review of mammalian toxicity of ZnO nanoparticles
Vandebriel, R., & De Jong, W. (2012) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s23932 · Cited by 494
Toxicologic effects of gold nanoparticles in vivo by different administration routes
Zhang (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s8428 · Cited by 490
Lanone, S., Rogerieux, F., Geys, J., Dupont, A., Maillot-Marechal, E., Boczkowski, J., Lacroix, G., & Hoet, P. (2009) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-6-14 · Cited by 468
Toxicity assessment of nanomaterials: methods and challenges
Dhawan, A., & Sharma, V. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3996-x · Cited by 466
Current in vitro methods in nanoparticle risk assessment: Limitations and challenges
Kroll, A., Pillukat, M. H., Hahn, D., & Schnekenburger, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.009 · Cited by 465
Size-dependent in vivo toxicity of PEG-coated gold nanoparticles
Zhang, X.-D., Wu, Shen, Liu, Sun, Zhang, & Fan (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s21657 · Cited by 456
Zinc oxide nanoparticles in modern sunscreens: An analysis of potential exposure and hazard
Osmond, M. J., & Mccall, M. J. (2010) · Nanotoxicology · doi:10.3109/17435390903502028 · Cited by 452
Schmid, O., & Stoeger, T. (2016) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2015.12.006 · Cited by 449
Targeted delivery of nanoparticles for the treatment of lung diseases
Azarmi, S., Roa, W. H., & Löbenberg, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.006 · Cited by 440
“[90] evaluated several different particles and variables which strongly impact the ability of in vitro screening 9 S.”
BackgroundAhmad, A., Khan, A., Akhtar, F., Yousuf, S., Xess, I., Khan, L. A., & Manzoor, N. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1050-8 · Cited by 431
Are Quantum Dots Toxic? Exploring the Discrepancy Between Cell Culture and Animal Studies
Tsoi, K. M., Dai, Q., Alman, B. A., & Chan, W. C. W. (2013) · Accounts of Chemical Research · doi:10.1021/ar300040z · Cited by 420
Mahmoudi, M., Hosseinkhani, H., Hosseinkhani, M., Boutry, S., Simchi, A., Journeay, W. S., Subramani, K., & Laurent, S. (2011) · Chemical Reviews · doi:10.1021/cr1001832 · Cited by 418
Nanoparticles: a review of particle toxicology following inhalation exposure
Bakand, S., Hayes, A., & Dechsakulthorn, F. (2012) · Inhalation Toxicology · doi:10.3109/08958378.2010.642021 · Cited by 416
Cho, W.-S., Duffin, R., Howie, S. E., Scotton, C. J., Wallace, W. A., MacNee, W., Bradley, M., Megson, I. L., & Donaldson, K. (2011) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-8-27 · Cited by 415
Analytical methods to assess nanoparticle toxicity
Marquis, B. J., Love, S. A., Braun, K. L., & Haynes, C. L. (2009) · The Analyst · doi:10.1039/b818082b · Cited by 406
In vitro and in vivo toxicity assessment of nanoparticles
Kumar, V., Sharma, N., & Maitra, S. S. (2017) · International Nano Letters · doi:10.1007/s40089-017-0221-3 · Cited by 391
Testing Metal‐Oxide Nanomaterials for Human Safety
Landsiedel, R., Ma‐Hock, L., Kroll, A., Hahn, D., Schnekenburger, J., Wiench, K., & Wohlleben, W. (2010) · Advanced Materials · doi:10.1002/adma.200902658 · Cited by 387
Sung, J. H., Ji, J. H., Yoon, J. U., Kim, D. S., Song, M. Y., Jeong, J., Han, B. S., Han, J. H., Chung, Y. H., Kim, J., et al. (2008) · Inhalation Toxicology · doi:10.1080/08958370701874671 · Cited by 380
Xia, T., Zhao, Y., Sager, T., George, S., Pokhrel, S., Li, N., Schoenfeld, D., Meng, H., Lin, S., Wang, X., et al. (2011) · ACS Nano · doi:10.1021/nn1028482 · Cited by 379
Hanley, C., Thurber, A., Hanna, C., Punnoose, A., Zhang, J., & Wingett, D. G. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9413-8 · Cited by 374
In vitro Toxicity Testing of Nanoparticles in 3D Cell Culture
Lee, J., Lilly, G. D., Doty, R. C., Podsiadlo, P., & Kotov, N. A. (2009) · Small · doi:10.1002/smll.200801788 · Cited by 373
Nanomaterials in food and agriculture: An overview on their safety concerns and regulatory issues
Jain, A., Ranjan, S., Dasgupta, N., & Ramalingam, C. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1160363 · Cited by 367
George, S., Lin, S., Ji, Z., Thomas, C. R., Li, L., Mecklenburg, M., Meng, H., Wang, X., Zhang, H., Xia, T., et al. (2012) · ACS Nano · doi:10.1021/nn204671v · Cited by 366
Motskin, M., Wright, D. M., Muller, K., Kyle, N., Gard, T. G., Porter, A. E., & Skepper, J. N. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.044 · Cited by 364
In vivo toxicity of cationic micelles and liposomes
Knudsen, K. B., Northeved, H., Kumar EK, P., Permin, A., Gjetting, T., Andresen, T. L., Larsen, S., Wegener, K. M., Lykkesfeldt, J., Jantzen, K., et al. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.08.004 · Cited by 356
Effect of Nanoparticles on the Cell Life Cycle
Mahmoudi, M., Azadmanesh, K., Shokrgozar, M. A., Journeay, W. S., & Laurent, S. (2011) · Chemical Reviews · doi:10.1021/cr1003166 · Cited by 352
Toxicity of metal-based nanoparticles: Challenges in the nano era
Zhang, N., Xiong, G., & Liu, Z. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1001572 · Cited by 343
The physics of functional magnetic resonance imaging (fMRI)
Buxton, R. B. (2013) · Reports on Progress in Physics · doi:10.1088/0034-4885/76/9/096601 · Cited by 341
Clinical toxicities of nanocarrier systems.
Vega-Villa, K. R., Takemoto, J. K., Yáñez, J. A., Remsberg, C. M., Forrest, M. L., & Davies, N. M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.007 · Cited by 325
“Some clearance processes show particle size-dependent differences, and nano-selective effectiveness [2,7,31].”
BackgroundCho, W.-S., Duffin, R., Poland, C. A., Howie, S. E. M., MacNee, W., Bradley, M., Megson, I. L., & Donaldson, K. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002201 · Cited by 324
The toxicity of nanoparticles and their interaction with cells: an in vitro metabolomic perspective
Awashra, M., & Młynarz, P. (2023) · Nanoscale Advances · doi:10.1039/d2na00534d · Cited by 319
Fruijtier-Pölloth, C. (2012) · Toxicology · doi:10.1016/j.tox.2012.02.001 · Cited by 312
Pulmonary applications and toxicity of engineered nanoparticles
Card, J. W., Zeldin, D. C., Bonner, J. C., & Nestmann, E. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00041.2008 · Cited by 307
Warheit, D. B., Sayes, C. M., Reed, K. L., & Swain, K. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.07.001 · Cited by 297
Self-citationMahmoudi, M., Simchi, A., Imani, M., Shokrgozar, M. A., Milani, A. S., Häfeli, U. O., & Stroeve, P. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.08.044 · Cited by 294
Rancan, F., Gao, Q., Graf, C., Troppens, S., Hadam, S., Hackbarth, S., Kembuan, C., Blume-Peytavi, U., Rühl, E., Lademann, J., et al. (2012) · ACS Nano · doi:10.1021/nn301622h · Cited by 288
Sayes, C. M., Marchione, A. A., Reed, K. L., & Warheit, D. B. (2007) · Nano Letters · doi:10.1021/nl0710710 · Cited by 282
Self-citationCritical Review on the Toxicity of Some Widely Used Engineered Nanoparticles
Srivastava, V., Gusain, D., & Sharma, Y. C. (2015) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.5b01610 · Cited by 277
Bioavailability of Nanoscale Metal Oxides TiO2, CeO2, and ZnO to Fish
Johnston, B. D., Scown, T. M., Moger, J., Cumberland, S. A., Baalousha, M., Linge, K., van Aerle, R., Jarvis, K., Lead, J. R., & Tyler, C. R. (2010) · Environmental Science & Technology · doi:10.1021/es901971a · Cited by 275
A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping)
Arts, J. H. E., Hadi, M., Irfan, M.-A., Keene, A. M., Kreiling, R., Lyon, D., Maier, M., Michel, K., Petry, T., Sauer, U. G., et al. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.03.007 · Cited by 256
Self-citationLuo, Y.-H., Chang, L. W., & Lin, P. (2015) · BioMed Research International · doi:10.1155/2015/143720 · Cited by 254
Rushton, E. K., Jiang, J., Leonard, S. S., Eberly, S., Castranova, V., Biswas, P., Elder, A., Han, X., Gelein, R., Finkelstein, J., et al. (2010) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287390903489422 · Cited by 232
Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials
Landsiedel, R., Ma-Hock, L., Hofmann, T., Wiemann, M., Strauss, V., Treumann, S., Wohlleben, W., Gröters, S., Wiench, K., & van Ravenzwaay, B. (2014) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-11-16 · Cited by 169
“in vitro, ZnO nanomaterials have been recorded to be highly toxic to many types of cells with concordant effects observed in vivo upon instillation, to the lung tissue [8].”
BackgroundStepien, G., Moros, M., Pérez-Hernández, M., Monge, M., Gutiérrez, L., Fratila, R. M., las Heras, M. D., Menao Guillén, S., Puente Lanzarote, J. J., Solans, C., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b18648 · Cited by 158
Hazards and Risks of Engineered Nanoparticles for the Environment and Human Health
Hristozov, D., & Malsch, I. (2009) · Sustainability · doi:10.3390/su1041161 · Cited by 149
Larsen, S. T., Jackson, P., Poulsen, S. S., Levin, M., Jensen, K. A., Wallin, H., Nielsen, G. D., & Koponen, I. K. (2016) · Nanotoxicology · doi:10.1080/17435390.2016.1202350 · Cited by 79
“Thus Sayes et al. (2007) instilled 1 or 5 mg/kg of ZnO nanoparticles or fine ZnO particles intratracheally in rats.”
BackgroundPreparation of alginate coated Pt nanoparticle for radiosensitization of breast cancer tumor
Rashidzadeh, H., Seidi, F., Ghaffarlou, M., Salehiabar, M., Charmi, J., Yaray, K., Nosrati, H., & Ertas, Y. N. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123273 · Cited by 43
Bartlett, J. A., Brewster, M., Brown, P., Cabral-Lilly, D., Cruz, C. N., David, R., Eickhoff, W. M., Haubenreisser, S., Jacobs, A., Malinoski, F., et al. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9701-9 · Cited by 25
Self-citation
Metadata
- Authors
- Sayes, C. M., Reed, K. L., & Warheit, D. B.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-01
- Volume
- 97
- Issue
- 1
- Pages
- 163-180
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2163577514
- Cited by
- 762
- References
- 21
- FWCI
- 38.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.